Cite
Efficacy and safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: A randomized, controlled, open-label, blinded endpoint trial (NESICH).
MLA
Wang, Long, et al. “Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: A Randomized, Controlled, Open-Label, Blinded Endpoint Trial (NESICH).” International Journal of Stroke, vol. 19, no. 5, June 2024, pp. 587–92. EBSCOhost, https://doi.org/10.1177/17474930241232292.
APA
Wang, L., Zhou, T., Wang, P., Zhang, S., Yin, Y., Chen, L., Duan, H., Wu, N., Feng, H., & Hu, R. (2024). Efficacy and safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: A randomized, controlled, open-label, blinded endpoint trial (NESICH). International Journal of Stroke, 19(5), 587–592. https://doi.org/10.1177/17474930241232292
Chicago
Wang, Long, Tengyuan Zhou, Pangbo Wang, Shuixian Zhang, Yi Yin, Lin Chen, Haijun Duan, Na Wu, Hua Feng, and Rong Hu. 2024. “Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: A Randomized, Controlled, Open-Label, Blinded Endpoint Trial (NESICH).” International Journal of Stroke 19 (5): 587–92. doi:10.1177/17474930241232292.